Par Pharmaceutical
Organisation
Founded
Founded
5 Oct 2021
Sources: search.gleif.org
Trials
Phase 3, Terminated, 203 people, 26 Nov 2013
Phase 3, Terminated, 455 people, 29 Jul 2013
Phase 1, Completed, 24 people, 27 Jun 2011
Phase 1, Completed, 40 people, 27 Jun 2011
Phase 1, Completed, 24 people, 4 Apr 2008
Phase 1, Completed, 36 people, 4 Apr 2008
Phase 1, Completed, 24 people, 4 Apr 2008
Sources: clinicaltrials.gov